Produces plasmid for reasearch
Oxford Genetics has raised €8.1M across 1 funding round from 2 investors, most recently a round in Aug 2017. Based in UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-08-29 | Other | €8.1M |
| Invesco Perpetual,Mercia Technologies |
| View deal → |
